Arkadiusz Gajek

742 citations
35 papers · 569 indexed · h-index 16
Topics
PARP inhibition in cancer therapy (14 papers)DNA Repair Mechanisms (8 papers)Cell death mechanisms and regulation (8 papers)

In The Last Decade

Arkadiusz Gajek

34 papers receiving 563 citations

Peers

Arkadiusz Gajek
Comparison fields: 5 of 77
  • Molecular Biology 360
  • Oncology 240
  • Polymers and Plastics 67
  • Cancer Research 62
  • Organic Chemistry 58
Replace Hyunjin Park with:
Hyunjin Park South Korea
Yewei Zhu China
R. Löser Germany
Abraham H. Abouzeid United States
Dan Huang China
Yunduo Liu China
Dong‐Sheng Huang China
Meng Dong Germany
Said M. Afify Japan
Ezia Bello Italy
Arkadiusz Gajek relative to Hyunjin Park South Korea Hyunjin Park's profile →
Citations per field
00.5×4.5×
Hyunjin Park · 1×
Citations per year

Countries citing papers authored by Arkadiusz Gajek

Since Specialization
Citations

This map shows the geographic impact of Arkadiusz Gajek's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Arkadiusz Gajek with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Arkadiusz Gajek more than expected).

Fields of papers citing papers by Arkadiusz Gajek

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Arkadiusz Gajek. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Arkadiusz Gajek. The network helps show where Arkadiusz Gajek may publish in the future.

Co-authorship network of co-authors of Arkadiusz Gajek

This figure shows the co-authorship network connecting the top 25 collaborators of Arkadiusz Gajek. A scholar is included among the top collaborators of Arkadiusz Gajek based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Arkadiusz Gajek. Arkadiusz Gajek is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 0
2 2
3 19
4 2
5 17
6 15
7 5
8 11
9 29
10 14
11 62
12 10
13 12
14 5
15 17
16 18
17 23
18 16
19 52
20 34

About Arkadiusz Gajek

Arkadiusz Gajek is a scholar working on Oncology, Structural Biology and Physiology, having authored 35 papers that have together received 569 indexed citations. Recurring topics across this work include PARP inhibition in cancer therapy (14 papers), DNA Repair Mechanisms (8 papers) and Cell death mechanisms and regulation (8 papers). The work is most often cited by research in Oncology (240 citations), Reproductive Medicine (48 citations) and Molecular Biology (360 citations). Arkadiusz Gajek has collaborated with scholars based in Poland, United States and Germany. Frequent co-authors include Agnieszka Marczak, Aneta Rogalska, Zofia Jóźwiak, Agnieszka Śliwińska, Marzena Szwed, Barbara Klajnert‐Maculewicz, Anna Janaszewska, I. I. Tarasenko, Michał Gorzkiewicz and Józef Drzewoski. Their work appears in journals such as PLoS ONE, Scientific Reports and International Journal of Molecular Sciences.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026